IL33 and gestational diabetes: Less consistent is the behavior of IL‐33, an interleukin involved in the maintenance of tissue homeostasis, resolution of inflammation, and repair of tissue damage.36 IL‐33 is considered to have pro‐ and anti‐inflammatory actions and it is released after cell injury, acting as an alarm signal that alerts immune cells about tissue damage.37, 38 Our results showed a decreased IL‐33 expression in GDM‐derived AMSCs whereas in vitro control AMSCs exposed to a GDM‐like milieu showed an upward trend.